Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Name: Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
License: Public Domain

Sun Yat-sen University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nasopharyngeal carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 377417
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.